• 1. Which mechanism most directly explains blunted nocturnal dipping (non-dipping/reverse-dipping) in aldosterone-driven hypertension?*
  • 2. Why is 24-hour ABPM preferred over office BP for confirming nocturnal hypertension, dipping status, and BP variability?*
  • 3. In the phase 3 Bax24 trial, baxdrostat (an aldosterone synthase inhibitor) was assessed by 24-hour ABPM in patients with treatment-resistant hypertension. Compared with placebo at 12 weeks, which result is accurate?*
  • 4. Which ABPM-derived metric is most consistently associated with increased risk of CKD progression, heart failure, stroke, and cardiovascular mortality, independent of office BP control?*
  • What is your license?*
  • Please rate the extent to which this activity met the following objectives:

  • Learning Objectives
    Rows
  • Do you feel this activity was fair balanced and free of commercial bias?
  • This educational activity will result in a change in my role as a healthcare team member.
  • This educational activity will result in a change in my practice behavior.
  • Based on your participation in this activity, choose the statement(s) that applies to how your role as a healthcare team member will change:
  • Attestation to time spent on activity:

    AcademicCME designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™ or 1.0 CPE Contact Hours (0.10 CEUs) UAN # JA4008190-0000-26-019-L01-P.

    This program is accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC®) for 1.0 hours of effective education time. AcademicCME is an EBAC® Accredited Provider since 2026.

  • Please select your credit type from the below:*
  • AcademicCME thanks you for your participation in this activity. All information provided improves the scope and purpose of our programs.

  • Should be Empty: